Wai-Shiu, Fred Wong

Wong Wai-Shiu, Fred

Appointment(s)
  • Associate Professor, Department of Pharmacology
Administrative Appointment(s)
  • Head, Department of Pharmacology, NUS Yong Loo Lin School of Medicine
Academic Qualifications
  • PhD, The Ohio State University, USA
  • BPharm (cum laude), The St. John’s University, USA
Research Interest(s)
  • Asthma
  • COPD
  • Lung Fibrosis
  • Inflammation
  • Natural Products
  • Oligonucleotide Drugs
Recent Publications
  • 1. Tan WSD, Liao W, Zhou S, Mei D, Wong WSF. 2017 Dec. Targeting the renin–angiotensin system as novel therapeutic strategy for pulmonary diseases. Current Opinion in Pharmacology. 40:9-17. doi: 10.1016/j.coph.2017.12.002.
  • 2. Wong YK, Xu C, Kalesh KA, He Y, Lin Q, Wong WSF, Shen HM, Wang J. 2017 Nov. Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action. Medicinal Research Reviews. 37(6):1492-1517. doi: 10.1002/med.21446.
  • 3. Tran QTN, Wong WSF, Chai CLL. 2017 Oct. Labdane diterpenoids as potential anti-inflammatory agents. Pharmacological Research. 124:43-63. doi: 10.1016/j.phrs.2017.07.019.
  • 4. Peh HY, Tan WSD, Chan TK, Pow CW, Foster PS, Wong WSF. 2017 Sep. Vitamin E isoform gamma-tocotrienol protects against emphysema in cigarette smoke-induced COPD. Free Radical Biology and Medicine. 110:332-344. doi: 10.1016/j.freeradbiomed.2017.06.023.
  • 5. Tan WSD, Liao W, Zhou S, Wong WSF. 2017 Sep. Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of action. Biochemical Pharmacology. 139:71-81. doi: 10.1016/j.phrs.2016.12.010.